Trial
NCT04523727
Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
Phase IIISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Keryx Biopharmaceuticals
Collaborators
—
Condition
Hyperphosphatemia Related to Chronic Kidney Disease
Intervention
ferric citrate
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-22